The feasibility of using pathobiome strains as live biotherapeutic products for human use.
Jin P, Lin X, Xu W, Li K, Zhao X, Guo S, Zhao Z, Jiang L, Liao F, Chang L, Wang M, Liu Y, Huang S, Chen Z, Ji F.
Jin P, et al.
Imeta. 2024 May 26;3(3):e202. doi: 10.1002/imt2.202. eCollection 2024 Jun.
Imeta. 2024.
PMID: 38898988
Free PMC article.